Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Status: Unknown status Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20151
20162
20171
20181
20201
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Immunochina Medical Science & Technology Co., Ltd.1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Centre Hospitalier Universitaire Vaudois1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Hope Cancer Institute, Inc.1
ImmVira Pharma Co. Ltd1
NGM Biopharmaceuticals, Inc1
National University Hospital, Singapore1
OncoResponse, Inc.1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck16
Carcinoma, Non-Small-Cell Lung4
Head and Neck Neoplasms4
Melanoma3
Nasopharyngeal Neoplasms3
Breast Neoplasms2
Carcinoma, Squamous Cell2
Esophageal Neoplasms2
Hypopharyngeal Neoplasms2
Laryngeal Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.